Dent Neurologic

new masking policy – masks are now optional

DENTNeuro_White

PIONEER T3D: Clinical Study Evaluating Efficacy and Safety of T3D-959 in Mild-to-moderate Alzheimer’s Disease Subjects

Inclusion Criteria

  • Age 55-90 years
  • Have a reliable study partner, an identified adult who has sufficient contact to knowledgeably report on the subject’s daily cognition, function, behavior, safety, compliance and adherence.
  • Have a clinical diagnosis of mild-to-moderate AD
  • Visual and auditory acuity adequate for neuropsychological testing

For more information, call Dr Traci Aladeen at 716-558-9918 or email taladeen@dentinstitute.com. You can also visit https://clinicaltrials.gov/ct2/show/NCT04251182?term=T3D-959&draw=2&rank=1

Subscribe To Our Newsletter

Sign up to receive email updates on announcements, new services added, company updates & more!

Want to participate in a study?

Fill out the form below and one of our Research Coordinators will be in contact with you as soon as possible. If we currently do not have a study that is currently available for you, we will add you to our database for future studies.

Scroll to Top